IL6 and cancer: The upregulated genes showed significantly enriched GO terms, including response to interleukin-6, mitotic cell cycle phase transitions, and KEGG terms, including transcriptional misregulation in cancer, p53 signaling pathway, and cell cycle (Figures 6A, B).